Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Terrascend Corp TSNDF


Primary Symbol: T.TSND

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail... see more

TSX:TSND - Post Discussion

Terrascend Corp > IONC Reports record US8.3M 2nd Quarter sales
View:
Post by Acura001 on Aug 31, 2021 6:25am

IONC Reports record US8.3M 2nd Quarter sales

IONIC Brands Corp. Announces Record Sales of US$8.3 Million in Second Quarter 2021

Release Highlights Record High Revenue for Second Quarter 2021
(Expressed in US dollars, unless otherwise stated)

  • Record Q2-2021 sales revenues of $8.3M and realized $1.3M in gross profit representing a 16% gross margin for the second quarter 2021, a 1.2% decline on quarter-on-quarter growth due to our combined B2B wholesale business and entrance into the sales of lower margin flower sales compared to our concentrate segments.
  • Record H1 sales revenues of $12.5M which exceeds the entire fiscal year of 2020 revenues by $3.5M, representing a 40% increase in revenue YTD
  • The Company maintains its target on baseline revenues of over $28 million for annual 2021.
  • Improved balance sheet through the conversion of $12.9 million in secured debt to preferred equity
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities